Definium Therapeutics Inc.
DFTX | NASDAQ
$36.33
$0.00 (0.00%)
Nov 2, 2026, 9:30 AM ET · Market open
Market Data
Market Cap $4.88B
Enterprise Value $3.83B
Beta 2.19
Average Volume 2.34M
Shares Outstanding (Diluted) 110.68M
Shares Change YoY 29.69%
Institutional Ownership N/A
Exchange NASDAQ
ISIN CA24477V1058
Price Performance
Price Change 1M -4.5%
Price Change 3M -16.5%
Price Change 6M 67.4%
Price Change YTD 171.3%
Price Change 1Y 155.8%
Price Change 3Y 1319.1%
Price Change 5Y -3.9%
1M CAGR (ann.) -6.4%
1Y CAGR (ann.) 181.4%
5Y CAGR (ann.) -0.1%
All-Time CAGR 26.9%
Valuation
PE Ratio -10.59
Forward PE N/A
PEG Ratio 0.14
Forward PEG -0.18
PS Ratio N/A
Forward PS 166.30
PB Ratio 5.31
P/FCF Ratio -29.25
P/Adj. FCF Ratio -24.30
P/OCF Ratio -24.06
EV/Sales N/A
EV/EBIT -11.27
EV/EBITDA -11.29
EV/FCF -22.98
Earnings Yield -9.4%
FCF Yield -3.4%
Adj. FCF Yield -4.1%
Financial Health
Net Cash $1.05B
Total Debt $36.47M
Cash & Short-Term Investments $1.08B
Total Assets $1.11B
Current Ratio 6.95
Quick Ratio 6.95
Debt / Equity Ratio 0.04
Debt / EBITDA -0.11
Debt / FCF -0.22
OCF / Debt -4.58
Interest Coverage -16.92
Altman Z-Score 14.05
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -20.4%
Returns
Return on Assets -31.8%
Return on Equity -85.2%
Return on Invested Capital -23.8%
Return on Capital Employed -23.8%
Return on Tangible Assets -32.4%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -24.6%
EPS CAGR 5Y 15.8%
EPS CAGR 10Y 9.7%
FCF CAGR 3Y -40.8%
FCF CAGR 5Y -29.9%
FCF CAGR 10Y -33.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 44.0%
Revenue Growth Next 3Y N/A
Earnings Date Nov 9, 2026
EPS Estimate (next Q) -$0.56
EPS Growth Est (next Q) -27.8%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $67.45
Price Target Upside 85.7%
Cash Flow
Operating Cash Flow $-166.87M
Free Cash Flow $-166.87M
Adj. Free Cash Flow $-200.87M
FCF Per Share -$1.51
OCF Per Share -$1.51
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-227.54M
EBITDA $-339.7M
Net Income $-353.79M
EPS (Diluted) -$3.43
Revenue / Employee N/A
Profit / Employee $-3.34M
Employees 106
Add to Watchlist
Select watchlists to add or remove DFTX